BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 18158566)

  • 1. Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes.
    Varga G; Kiss J; Várkonyi J; Vas V; Farkas P; Pálóczi K; Uher F
    Pathol Oncol Res; 2007; 13(4):311-9. PubMed ID: 18158566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes.
    Tauro S; Hepburn MD; Bowen DT; Pippard MJ
    Haematologica; 2001 Oct; 86(10):1038-45. PubMed ID: 11602409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bone marrow stem stromal imbalance--a key feature of disease progression in case of myelodysplastic mouse model.
    Das M; Chatterjee S; Basak P; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
    J Stem Cells; 2010; 5(2):49-64. PubMed ID: 22049615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?
    Pleyer L; Valent P; Greil R
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27355944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble Jagged-1 is able to inhibit the function of its multivalent form to induce hematopoietic stem cell self-renewal in a surrogate in vitro assay.
    Vas V; Szilágyi L; Pálóczi K; Uher F
    J Leukoc Biol; 2004 Apr; 75(4):714-20. PubMed ID: 14742638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [mRNA expression of notch ligand-delta-like-1 and jagged-1 in mesenchymal stem cells of MDS patients].
    Fei CM; Gu SC; Zhao YS; Guo J; Li X; Chang CK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1656-60. PubMed ID: 25543492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow stromal cells from MDS and AML patients show increased adipogenic potential with reduced Delta-like-1 expression.
    Weickert MT; Hecker JS; Buck MC; Schreck C; Rivière J; Schiemann M; Schallmoser K; Bassermann F; Strunk D; Oostendorp RAJ; Götze KS
    Sci Rep; 2021 Mar; 11(1):5944. PubMed ID: 33723276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms.
    Horiguchi H; Kobune M; Kikuchi S; Yoshida M; Murata M; Murase K; Iyama S; Takada K; Sato T; Ono K; Hashimoto A; Tatekoshi A; Kamihara Y; Kawano Y; Miyanishi K; Sawada N; Kato J
    Haematologica; 2016 Apr; 101(4):437-47. PubMed ID: 26802051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow niche in the myelodysplastic syndromes.
    Cogle CR; Saki N; Khodadi E; Li J; Shahjahani M; Azizidoost S
    Leuk Res; 2015 Oct; 39(10):1020-7. PubMed ID: 26276090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ability of multipotent mesenchymal stromal cells from the bone marrow of patients with leukemia to maintain normal hematopoietic progenitor cells.
    Sorokina T; Shipounova I; Bigildeev A; Petinati N; Drize N; Turkina A; Chelysheva E; Shukhov O; Kuzmina L; Parovichnikova E; Savchenko V
    Eur J Haematol; 2016 Sep; 97(3):245-52. PubMed ID: 26643284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional disturbance of marrow stromal microenvironment in the myelodysplastic syndromes.
    Tauro S; Hepburn MD; Peddie CM; Bowen DT; Pippard MJ
    Leukemia; 2002 May; 16(5):785-90. PubMed ID: 11986938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.
    Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M
    Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biology of the bone marrow microenvironment and myelodysplastic syndromes.
    Rankin EB; Narla A; Park JK; Lin S; Sakamoto KM
    Mol Genet Metab; 2015; 116(1-2):24-8. PubMed ID: 26210353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of AURKA and AURKB genes in bone marrow stromal mesenchymal cells of myelodysplastic syndrome: correlation with G-banding analysis and FISH.
    Oliveira FM; Lucena-Araujo AR; Favarin Mdo C; Palma PV; Rego EM; Falcão RP; Covas DT; Fontes AM
    Exp Hematol; 2013 Feb; 41(2):198-208. PubMed ID: 23092930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luspatercept restores SDF-1-mediated hematopoietic support by MDS-derived mesenchymal stromal cells.
    Wobus M; Mies A; Asokan N; Oelschlägel U; Möbus K; Winter S; Cross M; Weidner H; Rauner M; Hofbauer LC; Bornhäuser M; Platzbecker U
    Leukemia; 2021 Oct; 35(10):2936-2947. PubMed ID: 34002031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro expansion of long-term repopulating hematopoietic stem cells in the presence of immobilized Jagged-1 and early acting cytokines.
    Kertész Z; Vas V; Kiss J; Urbán VS; Pozsonyi E; Kozma A; Pálóczi K; Uher F
    Cell Biol Int; 2006 May; 30(5):401-5. PubMed ID: 16621624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Delta1 and Jagged1 on early human hematopoiesis: correlation with expression of notch signaling-related genes in CD34+ cells.
    Neves H; Weerkamp F; Gomes AC; Naber BA; Gameiro P; Becker JD; Lúcio P; Clode N; van Dongen JJ; Staal FJ; Parreira L
    Stem Cells; 2006 May; 24(5):1328-37. PubMed ID: 16410393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Jagged-1 and its intracellular domain in human mesenchymal stromal cells differentially affect the interaction with hematopoietic stem and progenitor cells.
    Duryagina R; Thieme S; Anastassiadis K; Werner C; Schneider S; Wobus M; Brenner S; Bornhäuser M
    Stem Cells Dev; 2013 Oct; 22(20):2736-50. PubMed ID: 23758219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGFBI Expressed by Bone Marrow Niche Cells and Hematopoietic Stem and Progenitor Cells Regulates Hematopoiesis.
    Klamer SE; Dorland YL; Kleijer M; Geerts D; Lento WE; van der Schoot CE; von Lindern M; Voermans C
    Stem Cells Dev; 2018 Nov; 27(21):1494-1506. PubMed ID: 30084753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.